The role of biomarkers in the management of bone-homing malignancies
Bone represents a common site of metastasis from several solid tumours, including breast, prostate and lung malignancies. The onset of bone metastases (BM) is associated not only with serious skeletal complications, but also shortened overall survival, owing to the lack of curative treatment options...
Main Authors: | Stella DâOronzo, Janet Brown, Robert Coleman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-11-01
|
Series: | Journal of Bone Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212137417300775 |
Similar Items
-
Metastatic bone disease: Pathogenesis and therapeutic options
by: Stella D'Oronzo, et al.
Published: (2019-04-01) -
Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences
by: Stella D'Oronzo, et al.
Published: (2021-06-01) -
Evolving Role of Bone Biomarkers in Castration-Resistant Prostate Cancer
by: Janet E. Brown, et al.
Published: (2010-09-01) -
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
by: Stella D’Oronzo, et al.
Published: (2020-04-01) -
Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases
by: Steven L. Wood, et al.
Published: (2020-07-01)